Owlstone Medical

Owlstone Medical is a global leader in Breath Biopsy® technology for early disease detection and precision medicine. They develop and commercialize diagnostic tests and point-of-care devices using breath analysis for various diseases, including lung cancer, liver disease, and digestive diseases. Their unique value proposition lies in the non-invasive nature and potential for early detection offered by their Breath Biopsy® platform.

Funding Round: Series E

Funding Amount: $27M

Date: 15-Jan-2025

Investors: Ventura Capital, Aviva Ventures, Horizons Ventures, Gates Foundation

Markets: Healthtech, Medical Devices, Diagnostics, Artificial Intelligence & Machine Learning, Oncology, Life Sciences

HQ: Cambridge, Cambridgeshire, United Kingdom

Founded: 2004

Website: https://www.owlstonemedical.com

LinkedIn: https://www.linkedin.com/company/owlstonemedical

Twitter: https://twitter.com/owlstonemedical

Instagram:

Facebook: https://www.facebook.com/owlstonemedical